Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.56 USD | -3.11% | -11.86% | -34.73% |
05-15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
05-09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.73% | 64.66M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- Rallybio Says Ongoing Phase 1/2 Trial Shows 'Significant Benefit' Over Placebo for Rare Disease Drug RLYB211